Pluristem Therapeutics, Inc. develops Messenchymal stem cell production technology and commercializes cell therapy products. The Company focuses on cell therapy to treat severe blood, cardiovascular, autoimmune, and other disorders.
more
Refresh
Request Primer
No publications yet
No AI primers are available right now. Create one using Smartkarma AI.